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Abstract
We characterized the overall early effect of chronic ochratoxin A (OTA) treatment on rat liver, analyzing different aspects related
to: (i) fibrosis, by measuring collagen content and turnover, and -smooth muscle actin (SMA); (ii) oxidative stress and stress
response, by analyzing protein carbonylation, superoxide dismutase (SOD) and heat shock protein (HSP70) gene expression; (iii)
the possible tumor promoter effect, evaluating cadherin and connexin (CX) mRNA levels. Light microscopy analysis showed no
histological differences in OTA-treated and control (CT) rats. Collagen content, determined by computer analysis of Sirius red-
stained liver sections, was similar in both groups. In liver homogenates COL-I, COL-III, TIMP-1 and TGF-1 mRNA levels and
SMA were unaffected by OTA. Matrix metalloproteinase (MMP)-1, MMP-2 and MMP-9 protein levels were also similar in the
two groups. Protein carbonylation, a marker of severe oxidative stress, was not evident in the homogenates of OTA-treated livers;
superoxide dismutase (SOD) mRNA tended to be lower and HSP70 was strongly down-regulated. OTA reduced E-cadherin and
DSC-2 transcription, and down-regulated liver CX26, CX32 and CX43. In conclusion, these in vivo results show that OTA-induced
liver injury involves a reduction in the ability to counterbalance oxidative stress, maybe leading to altered gap junction intercellular
communication and loss of cell adhesion and polarity. This suggests that mild oxidative damage might be a key factor, in combination
with other cytotoxic effects, in triggering the promotion of liver tumors after exposure to OTA.
© 2006 Elsevier Ireland Ltd. All rights reserved.
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1. IntroductionThe mycotoxin ochratoxin A (OTA) is produced by
some species of fungi such as Aspergillus and Penicil-
lum, as a secondary metabolite during storage of food.
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t is thus a widespread contaminant of a variety of ani-
al and human foodstuffs, including cereal and grain
roducts, coffee, beer and wine (O’Brien and Dietrich,
005 for review). Contamination of food samples with
TA and the identification of OTA in blood of animals
nd humans living in endemic regions have been fre-
uently described after consumption of contaminated
ood (Petkova-Bocharova et al., 1988; Li et al., 2000).
OTA exerts several toxic effects, mainly involving the
idney and liver. It is also a strong carcinogen in rats and
ice (Petzinger and Ziegler, 2000), with immunosup-
ressive, teratogenic and genotoxic activity, and affects
lood coagulation and carbohydrate metabolism (Pfohl-
eszkowicz et al., 2002). Epidemiological studies have
rovided evidence of a correlation between high OTA
evels in blood and foods, and the development of Balkan
ndemic nephropathy, a chronic renal disease causing
rogressive fibrosis and impaired function, where exten-
ive contamination with OTA is described (Petkova-
ocharova et al., 1988; Vrabcheva et al., 2004).
The metabolic pathway of OTA and its effects vary
rom one tissue to another and although OTA-induced
ephrotoxicity has been widely described, analysis of the
verall effects of OTA on liver is still scant. To assess the
uman health risk posed by OTA the molecular events it
riggers in the liver must be known. We therefore used
orphological, molecular and biochemical methods to
nvestigate the overall early alterations underlying OTA
epatotoxicity experimentally in an in vivo model. Our
rst goal was to see whether OTA induced fibrosis like
n the kidney, so we investigated liver histology and the
xpression of genes and proteins involved in the colla-
en turnover pathway. Second, since OTA is reported to
romote epithelial-to-mesenchymal transition (EMT) in
idney, we checked whether the toxin also modified the
pithelial hepatocyte phenotype, particularly the expres-
ion of cadherins. Since OTA acts as a carcinogen, we
nalyzed whether it triggered carcinogenicity in the liver
y epigenetic mechanisms, modifying the hepatocyte
ap junction apparatus and influencing the expression of
pecific markers such as alpha-fetoprotein (AFP). Last, it
as been reported that OTA toxicity is mediated by oxida-
ive pathways (Baudrimont et al., 1994), so we analyzed
rotein carbonylation in liver homogenates, as a marker
f severe oxidative stress damage, and the stress response
nduced in liver cells by chronic exposure to OTA.
. Materials and methods.1. Animals
Sixteen male Wistar rats weighing 180–200 g and housed in
ingle metabolic cages with controlled temperature (25 ◦C) andy 225 (2006) 214–224 215
a 12-h alternating light–dark cycle were fed standard chow and
had free access to drinking water. All animals received humane
care and experiments were conducted in accordance with local
ethical committee guidelines.
Rats were divided into two groups of eight, as follows:
• Group 1 (CT): untreated controls. Each rat was given 0.5 mL
of saline by gastric gavage.
• Group 2 (OTA): OTA-treated rats. Rats were given a con-
stant dose of OTA (Sigma–Aldrich), 289g/kg body weight
every other day for 90 days by gastric gavage, as previously
reported (Baudrimont et al., 1994). OTA was dissolved in
0.1 M NaHCO, pH 7.4, then diluted in 0.5 mL saline.
Finally, after 90 days the animals were weighed, euthanased
by an anesthetic overdose (chloral hydrate), and the livers were
removed. Liver fragments were processed for morphological
examination or immediately frozen and stored at −80 ◦C for
molecular analysis.
2.2. Clinical chemistry
Aspartate aminotransferase (AST), alanine aminotrans-
ferase (ALT), lactate dehydrogenase (LDH) and albumin
(ALB) in plasma were assayed using standard protocols,
according to the manufacturers’ instructions.
2.3. Histochemistry and image analysis
Immediately after removal, liver fragments were fixed in
4% formalin in 0.1 M phosphate-buffered saline (PBS), pH
7.4, routinely dehydrated and paraffin-embedded. Serial sec-
tions (5m thick) interspaced at 100m were stained with
hematoxylin–eosin, for routine histopathology, or Sirius red.
For Sirius red staining, slides were de-paraffined and immersed
for 30 min in saturated aqueous picric acid containing 0.1% Sir-
ius red F3BA (Sigma, Milan, Italy), which specifically stains
COL proteins distinctly red. Five sections were examined for
each rat liver.
All the Sirius red-stained sections were analyzed by light
microscopy and the images were captured and digitalized using
an image analysis system with specific software (Isole, ICH,
Italy). This software automatically selects the collagenous por-
tion on the basis of similarities in the color of adjacent pixels,
based on an RGB system. Tissue COL content is expressed by
a fibrosis index (%) that indicates the mean Sirius red-stained
area as a percentage of the mean whole area of the section,
calculated as the mean of the fibrosis indexes for each section
for each rat.
2.4. RT-PCRTotal RNA was extracted from approximately 100 mg
of frozen liver by a modification of the acid guanidinium
thiocyanate–phenol–chloroform method (Tri-Reagent, Sigma,
Milan, Italy). RNA purity and concentration were determined
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Table 1
Primers sequences and RT-PCR amplification conditions
Gene Primer sequence Annealing
temperature (◦C)
No. of cycles bp
COL-I 5′-TTGACCCTAACCAAGGATGC 5′-CACCCCTTCTGCGTTGTATT 54 30 197
COL-III 5′-AGGCCAATGGCAATGTAAAG 5′-GGCCTTGCGTGTTTGATATT 53 32 187
TGF-β1 5′-CACCTGCACAGCTCCAGGCAC, 5′-CTTGCGACCCACGTAGTAGACG 53 32 153
TIMP-1 5′-TCCCCAGAAATCATCGAGAC, 5′-ATGGCTGAACAGGGAAACAC 55 32 329
AFP 5′-TGGAGAAGTGCTCCCAGTCT, 5′-GCAGTGGTTGATACCGGAGT 57 32 359
CX26 5′-TTAAAA CGTTGGCCT TTTGG, 5′-ACCCCATCTTGTTTCTGCAC 55 30 378
CX32 5′-AATGAGGCAGGATGAACTGG, 5′-CCTCAAGCCGTAGCATTTTC 55 28 339
CX43 5′-GCTCCACTCTCGCCTATGTC, 5′-TAGGTGCATGTTCTGCAAGC 55 30 390
E-cadherin 5′-GCAGTTCTGCCAGAGAAACC, 5′-AATCCTGCTTCCAGGGAGAT 55 28 315
N-cadherin 5′-TGTTGCTGCAGAAAACCAAG, 5′-GGCGACTCTCTGTCCAGAAC 53 28 309
DSG-2 5′-CCTTGGTGGACCAGCACTAT, 5′-GACAGCACCGTCTTCCTAGC 57 30 316
DSC-2 5′-CGTAATTCCCGTCCGAGTTA, 5′-TTGAGCTGTGAAGCCATTTG 55 30 386
HSP70 5′-CGCATCCCCCAAGGTGCAGAA, 5′-CCAAGCACCTTCTTCTTGGTCCA 55 32 691
CCA A
ATCTTSOD 5′-CGTCATTCACTTCGAGCAGA, 5′-CACCTTTGC
GAPDH 5′-ATGGTGAAGGTCGGTGTGAAC, 5′-GCTGACA
spectrophotometrically. One microgram of total RNA was
DNase I digested then reverse transcribed in 20L final vol-
ume of reaction mix (Promega Italia, Milan, Italy).
The primers and protocols for RT-PCR are listed in Table 1.
Amplification reactions were conducted in a final volume of
25L containing 2.5L of cDNA, 200M of the four dNTPs,
100 pmol of each primer, and 2.5 U of Taq DNA polymerase
(EuroTaq, Euroclone, Pero, Milan, Italy). Table 2 lists the RT-
PCR protocols. The RT-PCR products were electrophoresed on
1.5% agarose gels, stained with ethidium bromide and quan-
tified by densitometric analysis (Image Pro-Plus). The results
were normalized on GAPDH gene expression.
2.5. Protein analysis
Liver samples were homogenized in ice-cold extraction
buffer (1 mL/100 mg tissue) containing Tris–HCl 50 mM pH
7.5, NaCl 100 mM, CaCl2 2 mM. The homogenates were cen-
trifuged (4 ◦C, 5 min, 14,000 × g), and the supernatant was
decanted and saved on ice. The final concentration of the liver
extracts was determined with a standardized colorimetric assay
(DC Protein Assay, Bio-Rad, Segrate, Milan, Italy), and the
samples were divided into aliquots and stored at −20 ◦C.2.5.1. Western blot
For each sample 40g of total protein extracts were diluted
in SDS–sample buffer, loaded on 10% SDS-polyacrylamide
Table 2
Mean body weight (BW) and wet liver weight (LW), and ratio of LW
to BW in CT and OTA-treated rats
Treatment BW (g) LW (g) LW:BW ratio
CT 9.63 ± 1.12 413 ± 20.4 0.023 ± 0.003
OTA 9.56 ± 1.72 355 ± 31.8 0.027 ± 0.006
Data are mean ± S.D.GTCATCT 55 28 341
GAGGGAGT 54 28 473
gel, separated under reducing and denaturing conditions at
80 V according to Laemmli, and transferred at 90 V to a nitro-
cellulose membrane in 0.025 M Tris, 192 mM glycine, 20%
methanol, pH 8.3. After electroblotting, the membranes were
air-dried and blocked for 1 h, washed in TBST (TBS/Tween-20
0.05%) and incubated with the specific antibodies.
To measure matrix metalloproteinase (MMP)-1 and -2 the
membrane reacted with monoclonal antibodies to MMP-1
or MMP-2 (1g/mL in PBST/BSA 1%/NaN3 0.02%, Cal-
biochem, San Diego, CA, USA) overnight at 4 ◦C, and with an
HRP-conjugated rabbit anti-mouse serum (1:80,000 dilution,
Sigma, Milan, Italy); the immunoreactive bands were revealed
with an amplified Opti-4CN (Bio-Rad, Segrate, Milan, Italy)
and scanned densitometrically.
To assaySMA, membranes were incubated for 1 h at room
temperature in monoclonal antibody toSMA (1:500 in TBST:
Clone 1A4, Sigma, Milan, Italy) and in HRP-conjugated rab-
bit anti-mouse serum (1:80,000 dilution, Sigma, Milan, Italy).
Immunoreactive bands were revealed using Bio-Rad Opti-
4CN.
2.5.2. SDS-zymography
Liver extracts were thawed on ice and mixed 3:1 with
substrate gel sample buffer (10% SDS, 4% sucrose, 0.25 M
Tris–HCl pH 6.8, 0.1% bromophenol blue). Each sample
(30g) was loaded under non-reducing conditions onto elec-
trophoretic mini-gels (SDS-PAGE) containing 1 mg/mL of
type I gelatin (Sigma, Milan, Italy). The gels were run at a
running buffer temperature of 4 ◦C.
After SDS-PAGE the gels were washed twice in 2.5%
Triton X-100 for 30 min each, rinsed in water and incubated
overnight in a substrate buffer at 37 ◦C (Tris–HCl 50 mM,
CaCl2 5 mM, NaN3 0.02%, pH 8). The gels were stained
with Coomassie brilliant blue R250, and MMP gelatinolytic
activity was detected as clear bands on a blue background.
To confirm the identity of this activity, purified MMP-1 and
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Table 4
Effect of OTA on fibrosis-related gene expression
Treatment COL-I COL-III TIMP-1 TGF-1
CT 0.939 ± 0.06 1.18 ± 0.22 1.24 ± 0.06 1.04 ± 0.05
T
E
T
C
O
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MP-2 (100 ng, Calbiochem, San Diego, USA) were run as
tandards.
.5.3. Protein carbonyl detection by Western blotting
Anti-dinitrophenyl-KLH antibodies and horseradish
eroxidase-conjugated goat anti-rabbit IgG, were purchased
rom Molecular Probes (Eugene, OR, USA). The Opti-4CN
ubstrate Kit and Precision-Plus Protein standards, molecular
eights ranging from 10 to 250 kDa, were purchased from
io-Rad Laboratories (Hercules, CA, USA). All other
eagents were of analytical grade.
Protein samples (30g) were mixed with 2× SDS sample
uffer, then examined by SDS-PAGE using Criterion Tris–HCl
2.5% resolving gels (Bio-Rad Laboratories, USA). Gels were
tained with Coomassie Brilliant Blue R-250 to verify the
qual loading of samples. Samples were blotted at 100 V to
polyvinylidene difluoride membrane followed by deriva-
ization with 2,4-dinitrophenylhydrazine (DNPH, 0.1 mg/mL
n 2N HCl) (10). After washing and membrane blocking as
reviously described (Dalle-Donne et al., 2002), protein car-
onylation was evaluated immunologically for 2 h with anti-
NP-KLH antibody [1:10,000 dilution in 5% (w/v) dried,
on-fat milk in PBST: 10 mM Na-phosphate, pH 7.2, 0.9%
w/v) NaCl, 0.1% (v/v) Tween 20] followed by 1-h incuba-
ion with horseradish peroxidase-conjugated goat anti-rabbit
gG (1:2000 dilution in 5% (w/v) dried, non-fat milk in PBST)
Dalle-Donne et al., 2002). Immunoreactive bands were devel-
ped with the Opti-4CN Substrate Kit.
.6. Statistical analysis
Results are given as mean ± S.E.M. Experimental groups
ere compared by t-test. A p value < 0.05 was considered sig-
ificant.
. Results
.1. Liver and body weights and liver function
The liver weights (LW) and body weight (BW) of CT
nd OTA-treated rats are presented in Table 2. Neither
reatment had any effect on liver weight, and the ratio
f LW to BW was similar in all groups. Serum ALT
nd LDH tended to be higher after OTA. ALB and AST
ere respectively lowered and raised in OTA-treated rats
p < 0.05 versus CT) (Table 3).
able 3
ffect of OTA on clinical chemical parameters in rat blood
reatment Albumin (U/L) AST (U/L)
T 3.413 ± 0.25 148.3 ± 61.4
TA 2.736 ± 0.42* 208.0 ± 142.1
ata are mean ± S.D.
* p < 0.05 vs. CT.OTA 0.828 ± 0.08 1.22 ± 0.35 1.07 ± 0.06 0.95 ± 0.07
Data are expressed as normalized densitometric units and are
mean ± S.D.
3.2. Morphological and quantitative image analysis
Histopathological analysis of hematoxylin and eosin-
stained rat liver sections indicated that liver mor-
phology was the same in OTA-treated rats and CT,
although in some OTA-treated livers a mild steatosis
was detectable. Light microscopy of Sirius red-stained
paraffin-embedded liver sections indicated a similar
COL distribution in CT and OTA-treated rats. Accord-
ingly, COL content, expressed as the fibrosis index, was
not affected (0.86 ± 0.23 and 0.86 ± 0.12, respectively,
in CT and OTA-treated rats).
3.3. Expression of ﬁbrosis-related genes and
proteins in liver
COL-I and COL-III gene expressions were similar in
CT and OTA-treated rats, as also TIMP-1 and mRNA
TGF-1 mRNA levels (Table 4).
MMP-1 and MMP-2 fell slightly after OTA
(Figs. 1a, 2a, and 2b), while MMP-9 tended to be higher
(Figs. 1b and 2c). SMA was similarly expressed in the
two groups (Fig. 2d).
3.4. OTA-induced oxidative stress damage and
stress response
Protein carbonyl formation, indicative of severe
protein oxidation, was assayed in liver homogenates
by Western blotting, probed with anti-DNP antibody
after carbonyl derivatization with DNPH. OTA did
not increase the protein carbonyl content. However, it
strongly down-regulated HSP70 mRNA levels (74%,
p < 0.05 versus CT) (Fig. 3a). SOD also tended to be
lower (18%, p = 0.072) (Fig. 3b).
ALT (U/L) LDH (U/L)
39.5 ± 16.4 1365.5 ± 435.7
78.7 ± 52.1* 2340.8 ± 1806.0
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Fig. 1. (a) Western blot analysis for proMMP-1 and MMP-2. For
MMP-1, the antibody recognized positive bands in the 52/57 and
42/46 kDa regions corresponding respectively to the proenzyme and
Fig. 3. Bar graphs showing HSP70 (a) and SOD (b) mRNA levels inthe active forms of MMP-1. (b) Representative SDS-zymography
showing a lysis band consistent with proMMP-9. Each lane represents
a single rat.3.5. Liver connexin and cadherin gene expression
In liver homogenates CX26, CX32 and CX43 gene
expressions fell steeply after OTA (by respectively
Fig. 2. Bar graphs showing MMP-1 (a), proMMP-2 (b), proMMP-9 (c) and S
analysis of immunoreactive bands. Means ± S.E.M. of duplicate experimentsliver homogenates of CT and OTA-treated rats. Changes in mRNA
are expressed as normalized densitometric units relative to GAPDH
mRNA. Means ± S.E.M. *p < 0.05 vs. CT.
17%, 22% and 43%, p < 0.05 versus CT) (Fig. 4a–c).
The relative expression of the three connexins was
not affected (Fig. 4d). OTA had no effect on DSG-2
mRNA levels. By contrast, DSC-2 gene expression
was strongly down-regulated (23%, p < 0.05 versus
MA (d) protein levels in CT and OTA-treated rats after densitometric
.
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mig. 4. Bar graphs showing CX26 (a), CX32 (b) and CX43 (c) mRNA
re expressed as normalized densitometric units relative to GAPDH m
s. CT.
T) (Fig. 5a and b). N-cadherin tended to be reduced
17%, NS), and E-cadherin mRNA levels were also
owered by OTA (26%, p < 0.05 versus CT) (Fig. 5c
nd d).
ig. 5. Bar graphs showing DSG-2 (a), DSC-2 (b), E-cadherin (c) and N-ca
RNA are expressed as normalized densitometric units relative to GAPDH min liver homogenates of CT and OTA-treated rats. Changes in mRNA
(d) Relative expression of liver connexins. Means ± S.E.M. *p < 0.05
3.6. AFP mRNA levelsOTA increased AFP gene expression by 20.7% (p =
0.082) compared to CT (1.34 ± 0.11 versus 1.11 ± 0.05).
dherin (d) gene expression in CT and OTA-treated rats. Changes in
RNA. Means ± S.E.M. *p < 0.05 vs. CT.
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4. Discussion
4.1. Liver morphology and function
Descriptions of OTA-induced liver histological mod-
ifications vary. In line with others (Kamp et al., 2005a;
Mally et al., 2005a), we found no major morphological
changes in the livers of OTA-treated rats compared to
CT. The presence of a mild steatosis in OTA-treated rats,
although with the absence of other liver lesions, is con-
sistent with plasma AST and ALT. (Aydin et al. 2003),
however, reported granular and vacuolated degenera-
tion, cell necrosis, sinusoidal and central vein dilatation.
These differences are not the result of different regimens.
In fact, in both studies OTA was given either daily or on
alternate days. Therefore, the possibility that more fre-
quent repeated oral doses of OTA possibly caused a dose-
dependent rise in the OTA concentration in plasma and
liver, inducing more evident histopathological lesions,
cannot explain these results, and further studies will be
necessary.
4.2. Effect of OTA on collagen turnover
Light microscopy of Sirius red-stained liver sections
indicated a similar collagen content in CT and OTA-
treated rats, suggesting that the toxin did not trigger
a fibrotic process, unlike in the renal cortex (Gagliano
et al., 2005). However, since collagen turnover is a
highly tuned dynamic process, we examined whether
OTA affected the balance between COL synthesis and
degradation. Our data, showing a similar expression of
genes and proteins involved in the synthesis and degra-
dation pathways of COL, and of its modulation, sug-
gest that OTA did not affect collagen turnover at the
transcriptional, transductional and post-transductional
levels. These findings enlight that the molecular mecha-
nisms underlying OTA hepatotoxicity are different in the
liver and the kidney, and that fibrosis is not a histopatho-
logical lesion typical of OTA-induced liver injury. This
is supported by the similar SMA expression in both
experimental groups, indicative of a lack of activated
myofibroblasts in the liver of OTA-treated rats (Cassiman
et al., 2002).
4.3. Oxidative damage and heat shock response
Oxidative stress is the term generally used to describe
a condition in which cellular antioxidant defenses are
inadequate to completely inactivate the reactive oxygen
species (ROS) generated. On account of excessive ROS
production, loss of antioxidant defenses or both. Endoge-y 225 (2006) 214–224
nous antioxidant defenses include glutathione (GSH),
antioxidant vitamins and enzymes, such as SOD, cata-
lase (CAT), glutathione reductase (GR) and peroxidase
(GPx), as well as proteins involved in inducible cel-
lular defense mechanisms such as heat shock proteins
(HSP).
When ROS generation exceeds the rate at which
endogenous antioxidants can scavenge it, or when
endogenous antioxidant defenses are reduced or weak-
ened, macromolecules become targets for oxidative
modifications. Oxidative damage can severely compro-
mise cell homeostasis and viability, or induce a variety
of cellular responses through generation of secondary
reactive species, ultimately leading to cell death. The
effects of oxidative stress can be gleaned from the anal-
ysis of biomarkers of oxidative stress/damage, includ-
ing oxidatively modified DNA bases, lipid peroxidation
end-products, and oxidized proteins (Dalle-Donne et al.,
2006).
When eaten in food, OTA passes into the blood and
accumulates in organs such as the kidney and liver where,
according to several reports, it increases ROS produc-
tion (Schaaf et al., 2002). In rats repeated exposure
to OTA resulted in high plasma and organ concentra-
tions (increasing dose dependently). In the kidneys there
were also unusual changes in renal histopathology, but
in the liver there appeared to be no toxicity (Mally et
al., 2005a). Consistent with the lack of effects on lipid
peroxidation and the increase in DNA oxidative damage,
these findings suggested that overt oxidative stress lead-
ing to tissue necrosis is unlikely to account for the potent
toxicity of OTA.
An increase in malondialdehyde (MDA), a biomarker
of lipid peroxidation, was reported in serum and in the
liver and kidney of OTA-treated rats (Meki and Hussein,
2001; Ozcelik et al., 2004). MDA levels were measured
as thiobarbituric acid reactivity (TBARS) by spectropho-
tometric assay. Although this technique is easy to use,
the TBARS test is of questionable validity (Halliwell and
Whiteman, 2004). Therefore, although the TBARS assay
is accepted as an indicator of oxidative stress, it quantifies
MDA-like material and does not specifically measure
MDA or lipid peroxidation (Dalle-Donne et al., 2006).
Actually, MDA measured by gas chromatography–mass
spectrometry did not show any increase in rat plasma,
kidney and liver (Gautier et al., 2001).
OTA was reported to increase 8-oxo-7,8-dihydro-
2′deoxyguanosine (8-OH-dG) formation in rat liver and
kidney and in various cell lines (Schaaf et al., 2002;
Kamp et al., 2005a). However, in rats a single dose of
OTA did not induce 8-OH-dG formation in kidney DNA
(Gautier et al., 2001).
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Protein carbonylation is a sign of irreversible oxida-
ive damage, often leading to a loss of protein func-
ion, which may have lasting detrimental effects on cells
nd tissues (Dalle-Donne et al., 2003a). The formation
f protein carbonyls is currently the most widely used
arker of severe oxidative stress, and a number of assays
ave been developed for carbonyl quantification (Dalle-
onne et al., 2003b). We found no increase in protein
arbonylation in the liver of OTA-treated rats, in agree-
ent with observations in kidney and liver (Kamp et al.,
005a; Mally et al., 2005a).
Since non-specific oxidative damage is often
bserved during toxicity, it is difficult from the analysis
f MDA, 8-OH-dG, and protein carbonyls – presumed
ate biomarkers of oxidative stress/damage – to establish
hether severe oxidative stress is the cause or the con-
equence of OTA-induced cell toxicity. Levels of early
arkers of oxidative stress, including GSH and its oxi-
ized forms, antioxidant vitamins, antioxidant enzymes,
nd HSPs, may be altered in the presence of lower levels
f oxidative stress and before the biomarkers of severe
xidative stress attributed to cytotoxicity appear. The
lteration of early markers of oxidative stress, such as
he oxidative stress-responsive gene HO-1 and plasma
-tocopherol, without any increase in MDA or 8-OH-
G after OTA, suggests that oxidative stress might be
aused by some direct action of OTA (Gautier et al.,
001).
Low GSH concentrations in vitro (Schaaf et al., 2002;
amp et al., 2005b) and in vivo have been reported
fter exposure to OTA (Gautier et al., 2001; Meki and
ussein, 2001; Ozcelik et al., 2004), as well as decreases
n the activities of CAT, GPx, GR, and SOD in both
iver and kidney (Meki and Hussein, 2001; Ozcelik et
l., 2004). Here, we found that chronic treatment with
TA tended to reduce SOD mRNA levels, suggest-
ng that OTA affects SOD at the transcriptional level
oo.
Several HSPs are induced by oxidative stress and/or
xogenous chemical stressors at levels where no overt
evere oxidative stress and cytotoxicity is observed
Beyersmann and Hechtenberg, 1997). Both HSP32 and
SP70 are active in the cellular defense mechanisms
gainst stress injury. Normally, they act as molecu-
ar chaperones, performing important and well-known
ousekeeping functions. When cellular proteins become
oo oxidatively damaged to be repaired, chaperones
witch their function from protein folding to protein
igestion.
HSP32 was induced specifically in kidneys of OTA-
reated rats (Gautier et al., 2001). No changes in the
SP70 level were detected in LLC-PK1 and MDCKy 225 (2006) 214–224 221
cells treated with OTA (Barisic et al., 2002), and the
relative distribution of two HSP70 isoforms (68- and 74-
kDa isoform) was affected by OTA, but with no change
in the total amount of HSP70 in rat kidney (Barisic
et al., 2002). No information about inducible HSP70
expression in rat liver is available to date. We observed
significant down-regulation of HSP70 gene expression
in rats after exposure to OTA, suggesting that OTA
causes changes in critical proteins such as HSP70. Since
the transient induction of HSP70 produces a state of
increased resistance to further stress and the heat shock
response is generally thought to be an adaptive mecha-
nism to counteract adverse environmental conditions, the
absence or strong reduction of HSP70 protective effects
in hepatocytes might partly explain why the liver cannot
counterbalance injury after exposure to OTA; this quite
likely contributes at least partially to the mechanisms
of OTA-induced liver toxicity in rats during long-term
exposure.
Although OTA seems to induce mild oxidative stress
and it was suggested that the antioxidant melatonin might
protect against OTA toxicity in rat liver and kidney (Meki
and Hussein, 2001; Ozcelik et al., 2004; Abdel-Wahhab
et al., 2005), the absence of significant alterations in
a number of late biomarkers of severe oxidative stress
(e.g. protein carbonyls) after exposure to OTA (Kamp et
al., 2005a; Mally et al., 2005a,b) seems to indicate that
severe oxidative stress is not a major contributor to OTA
cytotoxicity.
4.4. OTA and tumor promotion
Although OTA is a nephrotoxic and tumorigenic
mycotoxin in experimental animals, we know little of
the mechanisms of these effects. Since carcinogenesis
consists of multiple stages and mechanisms, including
mutagenesis, cytotoxicity and epigenetic alterations, it
is important to clarify the potential mechanism by which
OTA affects both rodent and human cells.
Previous studies (Zepnik et al., 2001) found that OTA
did not exert a direct cytotoxic or genotoxic effect, since
after its biotransformation by cytochrome P450 no reac-
tive intermediates are formed capable of binding DNA.
However, non-cytotoxic levels of OTA induced epige-
netic mechanisms (Horvath et al., 2002), responsible in
part for the tumor promotion phase of carcinogenesis.
Many tumor promoters affect gap junction intercel-
lular communication (GJIC) and the expression of cad-
herins. GJIC plays a major role in maintaining tissue
homeostasis and regulating cell growth, development
and differentiation (Trosko and Ruch, 1998). Alter-
ations in GJIC by toxicants is a recognized cellular
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event involved in carcinogenesis, particularly in the
tumor-promoting process which facilitates clonal expan-
sion of initiated cells by non-genotoxic mechanisms
(Horvath et al., 2002; Yamasaki, 1990). The carcinogenic
process involves the transition from a normal, GJIC-
competent cell to one that is defective in GJIC, and most
tumor promoters appear to inhibit GJIC in cultured cells
(Budunova and Williams, 1994).
In adult liver, the main connexins are CX32 and
CX26, which are expressed by adult parenchymal cells
(hepatocytes). However, non-parenchymal liver epithe-
lial cells, hepatic fat-storing cells, express CX43 (Trosko
and Ruch, 1998). CX32, in particular, is the major gap
junction protein expressed in hepatocytes, constantly
expressed along the liver lobule (Spary et al., 1994).
To our knowledge, this is the first study of rat liver
GJIC after OTA treatment. OTA strongly reduced CX26,
CX32 and CX43 gene expressions, suggesting that the
toxin may exert a hepatotoxic effect as a non-genotoxic
tumor promoter (Trosko et al., 1998). Similarly, hepato-
toxicity induced by CCl4, which is thought to activate
the inflammatory response and whose action is medi-
ated by oxidative stress damage, reduced the expression
of CX32 and CX26 (Saez et al., 1987). In the light of
evidence of a major role of cell growth deregulation
when GJIC is reduced in neoplastic and carcinogen-
treated cells, it can be proposed that chronic exposure
to OTA may play a role in the promotion of hepato-
carcinoma. Several studies have in fact suggested that
CX32 expression had an inhibitory effect on hepatocar-
cinogenesis, and transfection with CX32 cDNA inhibits
the growth of hepatoma cells (Eghbali et al., 1991; Evert
et al., 2002). Interestingly, it was demonstrated a direct
connection between oxidative stress and CX32 down-
regulation (Kojima et al., 1996). Furthermore, a mod-
ification of the binding of transcription factors to reg-
ulatory sequences in CX32 promotor was suggested as
potential basis for this effect (Morsi et al., 2003). Accord-
ingly, we can hypothesize that OTA-induced oxidative
damage may affect CX32 gene expression by a similar
mechanism.
E-cadherin mediates cell–cell adhesion by associa-
tion with intracellular catenins. E-cadherin is the main
cadherin in the liver epithelium and its function may
decline in the malignant progression of various tumors
originating from epithelial cells, including liver tumors
(Kanai et al., 1997; Gao et al., 2006). A reduction
of E-cadherin, together with the down-regulation of
DSC-2 and the tendency to reduced N-cadherin, there-
fore suggests that a loss of hepatocyte adhesive prop-
erties and a cell polarized phenotype may induce cell
mobility, with a role in the mechanisms leading toy 225 (2006) 214–224
the development of hepatocarcinoma (Mareel et al.,
1997).
This idea is supported by our data showing a decrease
in serum ALB and induction of AFP gene expression.
The defective ALB production was reportedly due to
the reduction or absence of ALB gene transcription in
some hepatoma cells. Interestingly, ALB production was
increased in enhanced GJIC by CX32 gene transfection
(Yang et al., 2003).
5. Conclusions
These in vivo results show that the overall early
effects of OTA on liver are different from those described
in kidney, since the toxin did not exert a fibrogenic
role (Gagliano et al., 2005). OTA-induced liver injury
determines a weakening of the ability to counterbal-
ance oxidative stress, and in particular altered GJIC and
loss of cell adhesion and polarity. Since in vitro stud-
ies have shown that GJIC can be affected by oxidative
stress and since alterations of GJIC and E-cad expres-
sion contribute to the promotion phase of tumorigenesis
(Ruch and Klaunig, 1986; Gao et al., 2006), our find-
ings strongly support the hypothesis that long-lasting
OTA injury, such as mild oxidative damage in combi-
nation with other cytotoxic effects, might be the major
determinant in the mechanisms leading to the devel-
opment of hepatocarcinoma after a chronic exposure
to OTA.
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